期刊
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
卷 106, 期 6, 页码 1576-1584出版社
ENDOCRINE SOC
DOI: 10.1210/clinem/dgab147
关键词
LDL cholesterol; insulin secretion; type 2 diabetes; glucagon; insulin clearance
资金
- Federal Ministry of Education and Research (BMBF) [01GI0925]
This study found no association between LDL cholesterol and glucagon levels, but significant positive associations with C-peptide-based indices of insulin secretion, and negative associations with insulin-based secretion indices. LDL cholesterol levels were also positively associated with insulin clearance, both in the fasting state and post-glucose load.
Context: Pharmacological lowering of low-density lipoprotein (LDL) cholesterol potently reduces cardiovascular risk while concurrently increasing type 2 diabetes risk. Objective: The aim of this study was to investigate the relationship between LDL cholesterol concentrations and insulin secretion and glucagon levels. Methods: A total of 3039 individuals without cholesterol-lowering therapy, but with increased risk for diabetes, underwent routine blood tests and a 5-point oral glucose tolerance test (OGTT). Glucagon concentrations, insulin secretion, and insulin clearance indices were derived from the OGTT. Results: There was no association between LDL cholesterol and fasting glucagon (P =.7, beta = -.01) or post-glucose load glucagon levels (P =.7, beta = -.07), but we detected significant positive associations of LDL cholesterol and C-peptide-based indices of insulin secretion (area under the curve [AUC](C-Peptide(0-30min)/)AUC(Glucose(0-30min)): P <.001, beta =.06; AUC(C-Peptide(0-120min)) /AUC(Glucose(0-120min)): P <.001, beta = -.08). In contrast, we found a negative association of insulin-based insulin secretion indices with LDL concentrations (insulinogenic index: P =.01, beta = -.04; disposition index: P <.001, beta = -.06). LDL cholesterol levels, however, were positively associated with insulin clearance assessed from C-peptide and insulin concentrations, both in the fasting state and post-glucose load (P <.001, beta =.09 and P <.001, beta =.06, respectively). Conclusion: As C-peptide based indices reflect insulin secretion independent of hepatic clearance, our results indicate lower insulin secretion in case of lesser LDL cholesterol. This could explain deteriorating glycemic control in response to cholesterol-lowering drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据